Mikael Truedsson
Papers
1
Total Citations
13
H-Index
1
About
Mikael Truedsson is a respiratory researcher focused on the early detection and pathophysiology of chronic obstructive pulmonary disease (COPD) in smokers and former smokers. His work centers on identifying biomarkers that precede irreversible lung damage, aiming to shift COPD diagnosis from late-stage intervention to early prevention. His most cited study, a 2016 longitudinal protocol, challenges the conventional belief that only 15% of smokers develop COPD, arguing that most smokers experience some pulmonary impairment. This foundational work has garnered 13 citations and underscores the urgent need for better screening tools. Truedsson’s research contributes to a growing body of evidence that COPD is a progressive, underdiagnosed epidemic, not a binary outcome. By targeting early biomarkers, his studies have implications for personalized risk assessment and smoking cessation strategies. His work is particularly relevant for pulmonologists, epidemiologists, and public health researchers seeking to reduce the global burden of COPD—currently the third leading cause of death. Truedsson’s contributions highlight the critical window for intervention before irreversible airway obstruction sets in, making his research a cornerstone for future early-detection protocols.
Research Focus
Key Achievements
Top Papers
- 1